American Hair Research Society Alopecia Areata Summit 2022
Include: 6 videos + 1 pdf, size: 8.76 GB
Target Audience: dermatologists, pediatric dermatologists, primary-care clinicians
Information:
A clinically oriented summit focused on the biology, diagnosis, and management of alopecia areata across ages and severities. Faculty translate emerging evidence—including targeted immunomodulation—into practical treatment pathways and longitudinal care plans.
What You Will Learn
Pathophysiology and immunology of AA; phenotype spectrum and differential diagnosis
Diagnostic workup: history/exam patterns, trichoscopy, labs when indicated, and biopsy pearls
Treatment algorithms by severity and patient profile: topical/intralesional therapies, systemic options, and targeted agents
Pediatric and adolescent considerations; pregnancy/lactation updates
Managing comorbidities (atopy, autoimmunity, mood) and counseling for expectations
Longitudinal care: relapse prevention, side-effect monitoring, and shared decision making
Camouflage options, haircare counseling, and psychosocial support resources
Event Details
Format: Case-based lectures, expert panels, and interactive Q&A with take-home checklists
Structure: Biology/diagnostics → Therapeutics → Special populations → Long-term management & support
Who Should Attend
Dermatologists, pediatric dermatologists, primary-care clinicians with dermatology focus, NPs/PAs, residents/fellows, clinical researchers, and allied professionals supporting patients with hair disorders.
Why Attend
Convert evolving evidence into clear, patient-centered treatment plans
Improve safety and adherence with structured monitoring and education
Enhance quality of life through integrated medical and psychosocial care
Topics:
- 22-AHRS-AA-Summit-Program-final-web-1-up
- Opening Session and Keynote
- Session 1 Setting the Stage of Basics of Alopecia Areata
- Session 2 JAK Inhibitors and Alopecia Areata
- Session 3 Lessons from JAK Inhibitors in Inflamatory Skin Diseases
- Session 4 Emerging Topics in Alopecia Areata
- Session 5 Integration of JAK Inhibitors into Clinical Practice



